Evaluation of ADHD from childhood to adolescence- impact of medical treatment on autonomic nervous system parameters
- Conditions
- ADHD is a neurobehavioral developmental disorder which affects about 5% of children. In our clinical trial designed we would like to examine whether medical treatment with stimulants has an influence on autonomic nervous system parameters. Therefore children already taking their medication will be examined while ease and exertion. Children taking part must not suffer from any kind of cardiovascular desease.
- Registration Number
- EUCTR2009-011887-12-DE
- Lead Sponsor
- Praxis Prof. Koenig
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
ADHD diagnosis confirmed and already taking medication as prescribed
no cardiovascular deseases
age between 6-60 years
no other drug intake
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
ADHD diagnosis not confirmed
any kind of cardiovascular disease
age under 6 years or over 60
incompliance with treatment
ophthalmological diseases
addiction
pregnancy
mothers breast-feeding children
allergy or hypersensitivity to drug treatment
depression or other psychological disease
anorexia
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method